United States · FDA National Drug Code directory
Dovato
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49702-246_9b88da25-ebce-49ae-8c8a-dcee6f465957
- Product NDC
- 49702-246
- Form
- TABLET, FILM COATED
- Composition / generic term
- dolutegravir sodium and lamivudine
- Labeler
- ViiV Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190408
- Source listing expiry
- 20271231
Source-listed ingredients
- DOLUTEGRAVIR SODIUM — 50 mg/1
- LAMIVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13) · 49702-246-13
- 1 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK · 49702-246-33
- 1 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 49702-246-62
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →